Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-16 · accession 0000899243-22-018610 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-18 | 2022-05-16 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale | $251.19 | -133 | 64.9K | -0.2% | -$33.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | S | D | 11 | $246.21 | 64,882 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $246.21 (range $245.78 to $246.25). |
| 2 | Common | Common Stock | 2022-05-16 | S | D | 40 | $254.19 | 64,760 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $254.19 (range $253.74 to $254.57). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-05-16 | S | D | 10 | $252.66 | 64,800 | D | — | — | |
| 4 | Common | Common Stock | 2022-05-16 | S | D | 10 | $251.43 | 64,810 | D | — | — | |
| 5 | Common | Common Stock | 2022-05-16 | S | D | 32 | $250.78 | 64,820 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $250.78 (range $250.35 to $250.97). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2022-05-16 | S | D | 20 | $249.35 | 64,852 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $249.35 (range $249.24 to $249.45). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2022-05-16 | S | D | 10 | $247.95 | 64,872 | D | — | — |